Lakshmidurga Drugs & Intermediates Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.84 Cr
- Satisfied Charges ₹ 10.43 Cr
- Revenue Growth 72.79%
- Profit Growth 44.12%
- Ebitda 20.63%
- Net Worth 23.92%
- Total Assets 37.84%
About Lakshmidurga Drugs & Intermediates
Lakshmidurga Drugs & Intermediates Private Limited (LDIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 May 2009 and has a history of 15 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹17.84 Cr. The company has closed loans amounting to ₹10.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vijayakrishna Ravi and Sai Dodda serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233TG2009PTC063687
-
Company No.
063687
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 May 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Lakshmidurga Drugs & Intermediates Private Limited offer?
Lakshmidurga Drugs & Intermediates Private Limited offers a wide range of products and services, including Organic Compounds, Acetamide, Machining Job Work, Custom Manufacturing Service, Third Party Manufacturing Consultancy, Contract Manufacturing Services, Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Lakshmidurga Drugs & Intermediates?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijayakrishna Ravi
|
Managing Director | 15-May-2009 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sai Dodda
|
Whole-Time Director | 15-May-2009 | Current |
Financial Performance of Lakshmidurga Drugs & Intermediates.
Lakshmidurga Drugs & Intermediates Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.79% increase. The company also saw a substantial improvement in profitability, with a 44.12% increase in profit. The company's net worth Soared by an impressive increase of 23.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lakshmidurga Drugs & Intermediates?
In 2023, Lakshmidurga Drugs & Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹17.84 Cr
₹10.43 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 17.84 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2017 | Hdfc Bank Limited | ₹17.84 Cr | Open |
| 04 Dec 2010 | State Bank Of India | ₹4.80 Cr | Satisfied |
| 19 Nov 2010 | State Bank Of Hyderabad | ₹5.63 Cr | Satisfied |
How Many Employees Work at Lakshmidurga Drugs & Intermediates?
Lakshmidurga Drugs & Intermediates has a workforce of 24 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lakshmidurga Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lakshmidurga Drugs & Intermediates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
